Where GLP-1 Is Secreted & How It Controls Weight

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) is a hormone your body naturally produces in response to food intake, and its secretion location directly impacts how your metabolism functions. This hormone is released from intestinal cells called L-cells, which monitor nutrient absorption and communicate satiety signals to your brain. Knowing where GLP-1 originates helps explain why prescription GLP-1 medications like semaglutide have become transformative tools in precision weight loss.

The Intestinal Origin of GLP-1 Secretion

GLP-1 is manufactured and released by specialized enteroendocrine L-cells located throughout your small intestine and colon. These cells make up less than 1% of your intestinal lining but produce powerful metabolic signals whenever nutrients—especially glucose and amino acids—pass through your digestive tract. When you eat a meal containing carbohydrates or protein, L-cells detect these nutrients and immediately begin secreting GLP-1 into your bloodstream.

The distribution of L-cells varies along your digestive tract, with the highest concentration in your ileum (the final section of the small intestine) and colon. This strategic positioning allows your body to sense what you've eaten and adjust hunger hormones accordingly before you've finished your meal. This rapid feedback system evolved to prevent overeating and maintain energy balance under normal circumstances.

How GLP-1 Secretion Regulates Blood Sugar and Appetite

Once GLP-1 enters your bloodstream from intestinal L-cells, it travels to multiple target organs including the pancreas, stomach, and brain. In the pancreas, GLP-1 stimulates insulin release only when blood glucose is elevated, creating a glucose-dependent safety mechanism that prevents dangerous low blood sugar episodes. This mechanism is fundamentally different from older diabetes medications and explains why GLP-1 drugs carry lower hypoglycemia risk.

GLP-1's appetite-suppressing effects occur when the hormone reaches brain regions responsible for hunger regulation, particularly the hypothalamus. The hormone slows gastric emptying (the rate your stomach releases food into the small intestine), creating lasting fullness sensations that naturally reduce calorie intake. Clinical studies show that these dual mechanisms—improved blood sugar control and sustained satiety—combine to produce weight reductions of 15-22% over 68 weeks in adults with obesity.

Why Your Body May Underproduce GLP-1 Naturally

Despite having fully functional L-cells, many individuals with obesity or metabolic dysfunction show significantly reduced GLP-1 secretion responses to meals. Research suggests genetic variations in the GLP1R gene (such as rs6923761) and other peptide-pathway genes can influence how efficiently your intestinal cells produce this crucial hormone. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways including GLP-1 receptor sensitivity, revealing whether your genetic profile predisposes you toward lower natural GLP-1 output.

Environmental factors like chronic stress, processed food consumption, and sedentary habits also gradually impair L-cell function over time. When your body fails to produce adequate GLP-1 during meals, appetite regulation weakens and blood sugar spikes become more likely, creating a metabolic downward spiral. This is where therapeutic GLP-1 medications restore the satiety signaling your body should be producing naturally.

Compounded Semaglutide: Replacing Your Body's GLP-1 Deficit

Semaglutide is a synthetic GLP-1 receptor agonist—essentially a lab-engineered copy of your body's natural GLP-1 hormone. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, starting at $149 per month across all dose levels. Unlike older weight-loss medications, semaglutide mimics your intestinal L-cells' natural secretion pattern, activating the same metabolic pathways your body evolved for appetite and glucose control.

PlexusDx patients access semaglutide without requiring insurance or membership fees, with treatments eligible for HSA and FSA accounts. Your dose may need to increase over time as your body adjusts, but your price remains flat—PlexusDx doesn't charge flat per-compound pricing models. When combined with the Precision Peptide Genetic Test ($99 after your first month), you gain personalized insights into your GLP-1 receptor sensitivity and other peptide-pathway predispositions, optimizing which medication formulation works best for your genetics.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Where exactly does GLP-1 come from in my body?

GLP-1 is secreted from L-cells, specialized intestinal cells located primarily in your small intestine's ileum and your colon. These cells release GLP-1 directly into your bloodstream whenever you consume food containing carbohydrates or protein, triggering appetite and blood sugar signals within minutes.

What happens if my body doesn't produce enough GLP-1 naturally?

Insufficient GLP-1 production leads to weakened appetite regulation, stronger food cravings, and elevated post-meal blood sugar levels. Genetic variants in your GLP1R gene (like rs6923761) can predispose you toward lower GLP-1 sensitivity, which PlexusDx's Precision Peptide Genetic Test identifies, allowing personalized treatment recommendations.

How does semaglutide from PlexusDx replace my missing GLP-1?

PlexusDx compounded semaglutide injections mimic your body's natural GLP-1, activating the same brain and pancreatic receptors your intestinal L-cells would normally stimulate. Starting at $149 per month from licensed 503A pharmacies, semaglutide restores the satiety signals and glucose control your body should produce on its own.

Is compounded semaglutide as safe as FDA-approved GLP-1 medications?

PlexusDx sources all compounded medications from licensed 503A compounding pharmacies that follow rigorous pharmaceutical standards. While compounded medications are not FDA-approved, 503A pharmacies operate under strict federal oversight and pharmacy board regulations, ensuring quality and safety equivalent to brand formulations in clinical practice.

How can genetic testing improve my GLP-1 therapy outcomes?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes key variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways. This reveals whether your genetics favor semaglutide, tirzepatide, or combination therapy, allowing PlexusDx to optimize your personalized weight-loss protocol before escalating doses.

Where is GLP-1 Secreted? Understanding Its Role in Metabolism and Health